As of close of business last night, F-star Therapeutics Inc.’s stock clocked out at $5.61, up 0.72% from its previous closing price of $5.57. In other words, the price has increased by $+0.04 from its previous closing price. On the day, 112569 shares were traded. FSTX stock price reached its highest trading level at $5.68 during the session, while it also had its lowest trading level at $5.54.
To gain a deeper understanding of FSTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.40 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on July 15, 2022, Downgraded its rating to Neutral and sets its target price to $7 from $35 previously.
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.63 while its Price-to-Book (P/B) ratio in mrq is 2.15.
Stock Price History:
Over the past 52 weeks, FSTX has reached a high of $6.76, while it has fallen to a 52-week low of $2.07. The 50-Day Moving Average of the stock is 5.60, while the 200-Day Moving Average is calculated to be 4.71.
It appears that FSTX traded 200.66K shares on average per day over the past three months and 212.1k shares per day over the past ten days. A total of 21.86M shares are outstanding, with a floating share count of 21.10M. Insiders hold about 2.40% of the company’s shares, while institutions hold 46.00% stake in the company. Shares short for FSTX as of Oct 13, 2022 were 158.64k with a Short Ratio of 0.78M, compared to 241.87k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.73% and a Short% of Float of 0.74%.
As of right now, 4 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.79 for the current quarter, with a high estimate of -$0.68 and a low estimate of -$0.86, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.73, with high estimates of -$0.59 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$2.72 and -$3.18 for the fiscal current year, implying an average EPS of -$2.9. EPS for the following year is -$2.74, with 5 analysts recommending between -$2.2 and -$3.19.
A total of 4 analysts have provided revenue estimates for FSTX’s current fiscal year. The highest revenue estimate was $2.67M, while the lowest revenue estimate was $2.55M, resulting in an average revenue estimate of $2.58M. In the same quarter a year ago, actual revenue was $21.17M, down -87.80% from the average estimate.